We are live on ! Find out more
ICUI icon

ICU Medical

270 hedge funds and large institutions have $4.88B invested in ICU Medical in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 95 increasing their positions, 99 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more call options, than puts

Call options by funds: $29.6M | Put options by funds: $11.4M

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

10% more capital invested

Capital invested by funds: $4.45B → $4.88B (+$435M)

3.27% more ownership

Funds ownership: 91.47%94.74% (+3.3%)

4% less repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 99

8% less funds holding

Funds holding: 292270 (-22)

40% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 47

Holders
270
Holders Change
-22
Holders Change %
-7.53%
% of All Funds
5.86%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
28
Increased
95
Reduced
99
Closed
47
Calls
$29.6M
Puts
$11.4M
Net Calls
+$18.2M
Net Calls Change
+$15.8M

ICUI Hedge Fund Activity: Q2 2019 in Review

270 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q2 2019, worth a combined $4.88B — up 9.8% from $4.45B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ICUI and 28 opened new positions — a net loss of 19 holders — while 99 trimmed existing stakes and 95 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $148M. The largest seller was VOYA Investment Management, cutting an estimated $50.5M.

  • 270 institutional investors held ICU Medical (ICUI) as of Q2 2019, down from 292 in Q1 2019.
  • Funds reported $4.88B of ICU Medical stock for Q2 2019, up 9.8% quarter-over-quarter.
  • 28 funds opened new ICU Medical positions in Q2 2019 and 47 closed out, a net change of -19 holders.
  • The largest ICU Medical buyer in Q2 2019 was T. Rowe Price Associates, an estimated $148M added.
  • The largest ICU Medical seller in Q2 2019 was VOYA Investment Management, an estimated $50.5M sold.

Based on aggregated 13F filings for Q2 2019.